BIOSPAIN 2026

BIOSPAIN 2026

The leading biotechnology event in Southern Europe BIOSPAIN 2026 will be celebrated annually as of this year. This edition will be held in the Bilbao Exhibtion Centre from 29th September to 1st October 2026.

The event gathers companies, investors, institutions and professionals from across the global biotech ecosystem

The official BIOSPAIN 2026 website is now live, and delegate registration is open, along with the sale of exhibition spaces. Companies interested in showcasing their capabilities, strengthening their visibility and connecting with key stakeholders can now secure their booth and register attendees at the discounted early bird rates.

Last year’s edition confirmed the scale and impact of BIOSPAIN, with 2,400 registered attendees from 34 countries , +1,000 organisations, 140 investors from 76 diferent investmet firms, and 4,500 one-to-one meetings through the partnering platform.

BIOSPAIN 2026 will once again combine:

  • An international partnering platform with 30 minute on-site meetings.
  • A high-level conference agenda covering science, investment and innovation.
  • Multiple visibility and sponsorship opportunities, tailored to different strategic objectives.
  • Talent Day, a dedicated space connecting companies with biotech professionals and future talent.
  • Networking events where we combine fun with business.

Please, stay tuned for more information on the programme, speakers and activities which will be released in the coming months.

Register early and secure your place at BIOSPAIN 2026!

See you in Bilbao!


BioRN members receive a 10 % discount on ticket prices.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

BioMed X and Boehringer Ingelheim Expand XSeed Labs to Advance Next-Generation Eye Therapies

Ridgefield, CT, USA, July 9, 2026 – BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim today announced the launch of a new research team at XSeed Labs, the established innovation incubator embedded within Boehringer’s U.S. R&D headquarters in Ridgefield, Connecticut. The newly established research team, Team NIB (New Platform for Next-Generation Intraocular […]

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Clinical Trial on Mild Stroke: Inpatient or Outpatient Treatment?

Researchers at Heidelberg University’s Faculty of Medicine are investigating a new care model for older adults with mild strokes at the Heidelberg University Hospital’s Department of Neurology. The Joint Federal Committee (G-BA) is funding the ARTIFICE study with approximately 2.4 million euros. Full Text in German below. Klinische Studie zu leichtem Schlaganfall: stationär oder ambulant […]

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

Ardigen platform supports VERAXA’s in-house AI capabilities to optimize cancer target pair selection for conditionally active t cell engagers (TCEs) and antibody drug conjugates (ADCs) ZURICH, SWITZERLAND – July 13, 2026 — VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven computational partner for modern […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp